BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2539817)

  • 21. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro.
    Nogueira CW; Santos FW; Soares FA; Rocha JB
    Environ Res; 2004 Mar; 94(3):254-61. PubMed ID: 15016592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DMSA, DMPS, and DMPA--as arsenic antidotes.
    Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characterization of Cd²⁺ complexes in solution with DMSA and DMPS.
    Zeini Jahromi E; Gailer J; Pickering IJ; George GN
    J Inorg Biochem; 2014 Jul; 136():99-106. PubMed ID: 24367995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats.
    Flora SJ; Bhadauria S; Pant SC; Dhaked RK
    Life Sci; 2005 Sep; 77(18):2324-37. PubMed ID: 15964026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
    Gale GR; Smith AB; Jones MM; Singh PK
    Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.
    Bridges CC; Joshee L; Zalups RK
    Toxicol Sci; 2008 Sep; 105(1):211-20. PubMed ID: 18511429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic excretion after treatment of arsenic poisoning with DMSA or DMPS in mice.
    Maehashi H; Murata Y
    Jpn J Pharmacol; 1986 Jan; 40(1):188-90. PubMed ID: 3007828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
    Miller AL
    Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
    George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
    Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acid.
    Slikkerveer A; Noach LA; Tytgat GN; Van der Voet GB; De Wolff FA
    Analyst; 1998 Jan; 123(1):91-2. PubMed ID: 9581027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection.
    Zhu X; Lever SZ
    Anal Bioanal Chem; 2003 Oct; 377(4):666-9. PubMed ID: 12904952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats.
    Flora SJ; Dube SN; Arora U; Kannan GM; Shukla MK; Malhotra PR
    Biometals; 1995 Apr; 8(2):111-6. PubMed ID: 7734923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid.
    Aposhian HV; Mershon MM; Brinkley FB; Hsu CA; Hackley BE
    Life Sci; 1982 Nov; 31(19):2149-56. PubMed ID: 6294430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
    Bhadauria S; Flora SJ
    Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
    Bjørklund G; Mutter J; Aaseth J
    Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 99Tcm-diastereomeric dimercaptosuccinic acid complexes: comparison of their biodistribution.
    Awh OD; Kim JR; Shim SC
    Nucl Med Commun; 1989 Jun; 10(6):449-54. PubMed ID: 2549480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
    Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
    Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine mercury excretion following meso-dimercaptosuccinic acid challenge in fish eaters.
    Ruha AM; Curry SC; Gerkin RD; Caldwell KL; Osterloh JD; Wax PM
    Arch Pathol Lab Med; 2009 Jan; 133(1):87-92. PubMed ID: 19123743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biological fate of 14C-dimercaptosuccinic acid in monkeys and rabbits.
    Tillotson JA; Boswell G; Kincannon L; Speckman CL
    Mil Med; 1989 Sep; 154(9):444-9. PubMed ID: 2552353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.